Mostrar el registro sencillo del ítem

dc.contributor.authorDewidar, Omar
dc.contributor.authorLotfi, Tamara
dc.contributor.authorLangendam, Miranda
dc.contributor.authorParmelli, Elena
dc.contributor.authorSaz-Parkinson, ZuleiKa 
dc.contributor.authorSolo, Karla
dc.contributor.authorChu, Derek K
dc.contributor.authorMathew, Joseph L
dc.contributor.authorAkl, Elie A
dc.contributor.authorBrignardello-Petersen, Romina
dc.contributor.authorMustafa, Reem A
dc.contributor.authorMoja, Lorenzo
dc.contributor.authorIorio, Alfonso
dc.contributor.authorChi, Yuan
dc.contributor.authorCanelo-Aybar, Carlos
dc.contributor.authorKredo, Tamara
dc.contributor.authorKarpusheff, Justine
dc.contributor.authorTurgeon, Alexis F
dc.contributor.authorAlonso-Coello, Pablo
dc.contributor.authorWiercioch, Wojtek
dc.contributor.authorGerritsen, Annette
dc.contributor.authorKlugar, Miloslav
dc.contributor.authorRojas, María Ximena
dc.contributor.authorTugwell, Peter
dc.contributor.authorWelch, Vivian Andrea
dc.contributor.authorPottie, Kevin
dc.contributor.authorMunn, Zachary
dc.contributor.authorNieuwlaat, Robby
dc.contributor.authorFord, Nathan
dc.contributor.authorStevens, Adrienne
dc.contributor.authorKhabsa, Joanne
dc.contributor.authorNasir, Zil
dc.contributor.authorLeontiadis, Grigorios I
dc.contributor.authorMeerpohl, Joerg J
dc.contributor.authorPiggott, Thomas
dc.contributor.authorQaseem, Amir
dc.contributor.authorMatthews, Micayla
dc.contributor.authorSchünemann, Holger J
dc.contributor.authoreCOVID-19 recommendations map collaborators
dc.date.accessioned2022-11-15T08:30:27Z
dc.date.available2022-11-15T08:30:27Z
dc.date.issued2022-04-15
dc.identifier.citationBMJ Evid Based Med. 2022 Apr 15;bmjebm-2021-111866.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15132
dc.description.abstractObjectives: To evaluate the development and quality of actionable statements that qualify as good practice statements (GPS) reported in COVID-19 guidelines. Design and setting: Systematic review . We searched MEDLINE, MedSci, China National Knowledge Infrastructure (CNKI), databases of Grading of Recommendations Assessment, Development and Evaluation (GRADE) Guidelines, NICE, WHO and Guidelines International Network (GIN) from March 2020 to September 2021. We included original or adapted recommendations addressing any COVID-19 topic. Main outcome measures: We used GRADE Working Group criteria for assessing the appropriateness of issuing a GPS: (1) clear and actionable; (2) rationale necessitating the message for healthcare practice; (3) practicality of systematically searching for evidence; (4) likely net positive consequences from implementing the GPS and (5) clear link to the indirect evidence. We assessed guideline quality using the Appraisal of Guidelines for Research and Evaluation II tool. Results: 253 guidelines from 44 professional societies issued 3726 actionable statements. We classified 2375 (64%) as GPS; of which 27 (1%) were labelled as GPS by guideline developers. 5 (19%) were labelled as GPS by their authors but did not meet GPS criteria. Of the 2375 GPS, 85% were clear and actionable; 59% provided a rationale necessitating the message for healthcare practice, 24% reported the net positive consequences from implementing the GPS. Systematic collection of evidence was deemed impractical for 13% of the GPS, and 39% explained the chain of indirect evidence supporting GPS development. 173/2375 (7.3%) statements explicitly satisfied all five criteria. The guidelines' overall quality was poor regardless of the appropriateness of GPS development and labelling. Conclusions: Statements that qualify as GPS are common in COVID-19 guidelines but are characterised by unclear designation and development processes, and methodological weaknesses.es_ES
dc.description.sponsorshipCIHR (FRN VR4-172741 & GA3-177732) for COVID-19 recommendation mapping. AFT is the Chairholder of the Canada Research Chair in Critical Care Neurology and Trauma.es_ES
dc.language.isoenges_ES
dc.publisherBMJ Publishing Group es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCOVID-19es_ES
dc.subjectEvidence-Based Practicees_ES
dc.subjectHealth Services Researches_ES
dc.titleWhich actionable statements qualify as good practice statements In Covid-19 guidelines? A systematic appraisal.es_ES
dc.typejournal articlees_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.identifier.pubmedID35428695es_ES
dc.format.numberbmjebm-2021-111866es_ES
dc.identifier.doi10.1136/bmjebm-2021-111866es_ES
dc.contributor.funderCanadian Institutes of Health Research es_ES
dc.contributor.funderCanada Research Chairs es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn2515-4478es_ES
dc.relation.publisherversionhttp://dx.doi.org/10.1136/bmjebm-2022-111962es_ES
dc.identifier.journalBMJ evidence-based medicinees_ES
dc.repisalud.centroISCIII::Agencia de Evaluación de Tecnologías Sanitariases_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 Internacional